Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer

• US 6,033,654 A
• Filed: 05/02/1996
• Issued: 03/07/2000
• Est. Priority Date: 05/05/1995
• Status: Expired due to Term

• Current Assignee: Protein Polymer Technologies, Inc., Spine Wave Incorporated
• Original Assignee: Protein Polymer Technologies, Inc.
• Inventors: Cappello, Joseph, Stedronsky, Erwin R.
• Primary Examiner(s): Naff, David M.
• Application Number:
  US08/642,246
• Time in Patent Office: 1,405 Days
• Field of Search: 435/174, 435/180, 424/486, 426/78.02, 426/78.06, 514/2, 106/124.1, 530/350, 530/402, 530/810
• US Class Current: 424/78.02
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: A61L 24/106 Fibrin; Fibrinogen
• CPC Class Codes: A61L 24/108 Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
• CPC Class Codes: A61L 27/227 Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
• CPC Class Codes: A61P 17/00 Drugs for dermatological disorders
• CPC Class Codes: A61P 17/02 for treating wounds, ulcers, burns, scars, keloids, or the like
• CPC Class Codes: A61P 41/00 Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: C07K 14/001 by chemical synthesis
• CPC Class Codes: Y10S 530/81 Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier

Abstract

Proteinaceous polymers having repetitive units from naturally occurring structural proteins are employed as backbones for functionalities for crosslinking to provide strongly adherent tissue adhesives and sealants. Particularly, block copolymers having repeating units of elastin and fibroin are employed having lysine substitutions in spaced apart units, where the amino group can be crosslinked using difunctional crosslinking agents. The protein polymer contains at least 40 weight percent of repetitive units of 3 to 30 amino acids of at least one naturally occurring structural protein and at least two functional groups capable of reacting with a crosslinking agent to form a strongly adherent adhesive composition for bonding together separated tissue or for sealing tissue defects. A preferred adhesive composition contains glutaraldehyde or polymethylene diisocyanate and a protein block copolymer of at least 30 kD containing at least 70 weight percent of repetitive units of Gly-Ala-Gly-Ala-Gly-Ser and Gly-Val-Gly-Val-Pro, where in at least two units an amino acid is substituted with one of lysine or arginine, and the copolymer has a lysine and arginine equivalent weight in the range of 3 to 15 kD. The protein polymer is produced by recombinant DNA technology, and a kit may be formed containing the crosslinking agent and protein polymer.

Claims

1. A crosslinked protein composition, said protein prior to crosslinking comprising at least 70 weight % of repetitive units of Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO:

01) and Gly-Val-Gly-Val-Pro (SEQ ID NO;

02), where in at least two repetitive units an amino acid is substituted with at least one of lysine or arginine, said protein prior to crosslinking having a lysine and arginine equivalent weight in the range of 1 to 20 kD,

wherein said protein comprises at least two amino acids comprising a functional group that is capable of reacting with at least one of aldehyde, isocyanate, thioisocyanate and activated carboxy.

2. A kit comprising a polyfunctional crosslinking agent and a protein polymer comprising at least 40 weight % of repetitive units, wherein said repetitive units are Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO:

01) and Gly-Val-Gly-Val-Pro (SEQ ID NO;

02) and wherein both of said repetitive units are present to form a block copolymer protein, wherein said protein polymer comprises at least two amino acids that comprise functional groups capable of reacting with said crosslinking agent.

3. A kit according to claim 2, wherein at least one of said functional groups is amino.

4. A kit according to claim 2, wherein said functional groups are as a result of reacting a naturally occurring amino acid in said protein polymer with a polyfunctional compound without setting up of said composition.

5. A kit according to claim 2, wherein said repetitive units further comprise GXX, wherein the X'"'"'s are the same or different and X is any amino acid, at least 10 number % and not more than 60 number % of X'"'"'s being proline.

6. A kit according to claim 2, wherein said crosslinking agent has a plurality of reactive groups selected from the croup consisting of aldehyde, isocyanate, thioisocyanate and activated carboxy.

7. A kit comprising a protein block copolymer of at least 30 kD comprising at least 40 weight % of repetitive units of Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO:

01) and Gly-Val-Gly-Val-Pro (SEQ ID NO;

02), wherein at least two amino acids of said protein block copolymer are substituted with lysine or arginine, said copolymer having a lysine and arginine equivalent weight in the range of 1 to 40 kD, and a crosslinking agent selected from the group consisting of glutaraldehyde and aliphatic diisocyanates.

8. A method of mairtaining separated viable tissue in proximate relationship, said method comprising:

applying to said separated viable tissue to hold together said tissue when said tissue is in contiguous relationship, a precursor composition comprising a polyfunctional crosslinking agent and a protein polymer comprising at least 40 weight % of repetitive units, wherein said repetitive units are Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO;

01) and Gly-Val-Gly-Val-Pro (SEQ ID NO;

02) and wherein both of said repetitive units are present to form a block copolymer protein, wherein said protein polymer comprises at least two functional groups capable of reacting with said crosslinking agent, whereby said precursor composition sets up to a strongly adherent adhesive composition;

with said separated viable tissue held in proximate relationship.

9. A method according to claim 8, wherein at least one of said functional groups is amino.

10. A method according to claim 8, wherein at least one of said functional groups is as a result of reacting a naturally occurring amino acid in said protein polymer with a polyfunctional compound without setting up of said composition.

11. A method according to claim 8, wherein said repetitive units further comprise GXX, wherein the X'"'"'s are the same or different and X is any amino acid, at least 10 number % and not more than 60 number % of X'"'"'s being proline.

12. A method according to claim 8, wherein said precursor composition further comprises a difunctional compound capable of reacting with said polyfunctional crosslinking compound.

13. A method according to claim 12, wherein said difunctional compound is lysine or arginine.

14. A method of maintaining separated viable tissue in proximate relationship, said method comprising:

applying to said separated viable tissue to hold together said tissue when said tissue is in contiguous relationship, a precursor composition comprising a polyfunctional crosslinking agent reactive with amino groups and a protein block copolymer comprising at least 40 weight % of repetitive units of Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO;

01) and Gly-Val-Gly-Val-Pro (SEQ ID NO;

02), wherein at least two amino acids of said protein block copolymer are substituted with lysine or arginine, whereby said precursor composition sets up to a strongly adherent adhesive composition;

with said separated viable tissue held in proximate relationship.

15. A method according to claim 14, wherein said protein block copolymer has an equivalent weight per lysine and arginine in the range of 1 to 40 kD.

16. A method according to claim 14, wherein each block of said block copolymer has at least two repetitive units and the ratio of Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO:

1) to Gly-Val-Gly-Val-Pro (SEQ ID NO;

2) is in the range of 1;

1-16.

17. A method according to claim 14, wherein said crosslinking agent has a plurality of amino reactive groups selected from the group consisting of aldehyde, isocyanate, thioisocyanate and activated carboxy.

18. A method according to claim 17, wherein said reactive group is isocyanate.

19. A method according to claim 14, wherein said precursor composition further comprises at least one of lysine or arginine.

20. A method of maintaining separated viable tissue in proximate relationship, said method comprising:

applying to said separated viable tissue to hold together said tissue when said tissue is in contiguous relationship, a precursor composition comprising a polyfunctional crosslinking agent selected from the group consisting of glutaraldehyde and polymethylene diisocyanate and a protein block copolymer of at least 30 kD comprising at least 40 weight % of repetitive units of Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO;

01) and Gly-Val-Gly-Val-Pro (SEQ ID NO;

02), wherein at least two amino acids of said protein block copolymer are substituted with lysine or arginine, said copolymer having a lysine and arginine equivalent weight in the range of 3 to 15 kD, whereby said precursor composition sets up to a strongly adherent adhesive composition;

with said separated viable tissue held in proximate relationship.

21. A method of sealing a defect in viable tissue, said method comprising:

applying to said defect a precursor composition comprising a polyfunctional crosslinking agent and a protein polymer comprising at least 40 weight % of repetitive units, wherein said repetitive units are Gly-Ala-Gly-Ala-Gly-Ser (SEQ ID NO;

01) and Gly-Val-Gly-Val-Pro (SEQ ID NO;

02) and wherein both of said repetitive units are present to form a block copolymer protein, wherein said protein polymer comprises at least two amino acids comprising functional groups capable of reacting with said crosslinking agent, which functional groups react with said crosslinking agent, whereby said precursor composition sets up to a strongly adherent adhesive composition;

whereby said defect is sealed.

22. A method according to claim 21, wherein said repetitive units further comprise CXX, wherein the X'"'"'s are the same or different and X is any amino acid, at least 10 number % and not more than 60 number % of X'"'"'s being proline.

23. A method according to claim 21, wherein said tissue is the wall of a vessel of the cardiovascular system, lung, dura or colon.

24. A method of maintaining separated viable tissue in proximate relationship, said method comprising:

applying to said separated viable tissue to hold together said tissue when said tissue is in contiguous relationship, a precursor composition comprising (1) a polyfunctional crosslinking agent comprising 2-aminoethyl glycinate, cholinyl lysinate or 1,3-propanediyl glycinate reacted with a difunctional compound which reacts with amino groups, and (2) a protein polymer comprising at least 40 weight % of repetitive units of from 3 to 30 amino acids of at least one naturally occurring structural protein, where there are at least two amino functional groups present in said protein polymer, which amino functional groups react with said crosslinking agent, whereby said precursor composition sets up to a strongly adherent adhesive composition;

with said separated viable tissue held in proximate relationship.